Basilea Pharmaceutica AG (BPMUF)
OTCMKTS · Delayed Price · Currency is USD
67.75
+6.41 (10.45%)
At close: Jul 30, 2025
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of $722.27 million as of September 5, 2025. Its market cap has increased by 15.00% in one year.
Market Cap
722.27M
Enterprise Value
682.65M
Revenue
297.01M
Ranking
n/a
PE Ratio
7.91
Stock Price
$67.75
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 418.27M to 722.27M, an increase of 72.68%. That is a compound annual growth rate of 2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 722.27M | 30.71% |
| Dec 30, 2024 | 552.59M | 10.03% |
| Dec 29, 2023 | 502.22M | -14.92% |
| Dec 30, 2022 | 590.31M | 11.34% |
| Dec 30, 2021 | 530.19M | -18.41% |
| Dec 30, 2020 | 649.82M | 25.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 760.21M |
| Tian'an Technology Group | 673.67M |
| Glass House Brands | 576.95M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 387.41M |
| American Oncology Network | 352.23M |